What CMS’s 2026 Prior Authorization Reporting Rules Mean for Patients and Clinicians

Practical takeaway: Beginning in 2026, many health plans will have to publicly report how often they approve or deny prior authorization requests—and how long those decisions take. For patients and clinicians, that means new visibility into a process that often delays care.

In 2024, the Centers for Medicare & Medicaid Services (CMS) finalized a major rule aimed at improving electronic data exchange and reforming prior authorization. Under that rule—known as CMS-0057-F—key transparency and reporting requirements take effect in 2026 for Medicare Advantage plans, Medicaid and CHIP managed care plans, and Qualified Health Plans (QHPs) on the federally facilitated Marketplace.

As someone who covers public health and health policy, I see this as less about headlines and more about everyday impact: how quickly a prescription gets approved, whether a surgery is delayed, and how much time clinicians spend on paperwork instead of patient care.

First, what is prior authorization?

Prior authorization (sometimes called “pre-approval”) is when a health plan requires approval before it will pay for a service, test, or medication. It’s common for higher-cost imaging (like MRIs), specialty drugs, some procedures, and even certain dental or oral surgeries under medical coverage.

Health plans say prior authorization helps ensure care is medically necessary and evidence-based. But patients and clinicians have long reported delays, denials, and administrative burdens.

Data summarized by KFF show that Medicare Advantage plans process tens of millions of prior authorization requests each year, with a portion denied and some later overturned on appeal. MedPAC, which advises Congress on Medicare policy, has also raised concerns about inappropriate denials and the burden on beneficiaries and clinicians.

What exactly changes in 2026?

According to CMS’s fact sheet and the full CMS-0057-F rule, affected plans must begin publicly reporting specific prior authorization metrics in 2026. These include:

The number of prior authorization requests received.
Approval and denial rates.
The average time taken to make a decision.
How many requests were approved after an appeal.

Plans must make this information publicly available, typically on their websites, in a standardized format.

In addition, the rule requires plans to implement electronic prior authorization application programming interfaces (APIs). In plain language, that means health systems and clinicians can submit and track prior authorization requests electronically through standardized systems rather than relying heavily on fax or manual portals.

Why transparency matters for patients

For many families, prior authorization isn’t an abstract policy issue. It can mean:

Delays in starting a new medication for diabetes, cancer, or autoimmune disease.
Postponed imaging to evaluate severe back pain or possible stroke symptoms.
Interrupted therapy services for children with developmental conditions.

When plans begin publishing approval rates and average decision times, patients may be able to compare how different plans perform. For example:

Does one Medicare Advantage plan approve requests faster than another?
Are denial rates significantly higher in one Marketplace plan?

That kind of information could influence enrollment decisions during open enrollment periods.

However, transparency alone does not guarantee faster approvals. CMS requires reporting, but the rule does not automatically cap denial rates or eliminate prior authorization requirements. Whether public reporting changes plan behavior remains to be seen.

What it could mean for clinicians

Physicians and other clinicians have long described prior authorization as a major administrative burden. The American Medical Association (AMA) has reported that many practices devote significant staff time to managing requests and appeals.

The new electronic API requirements are intended to streamline this process. If implemented well, electronic submission and real-time status updates could reduce phone calls, faxes, and repeated documentation.

In theory, that could mean:

Less time spent on paperwork.
Faster decisions for urgent requests.
More consistent documentation requirements.

But implementation will matter. Health Affairs policy analyses have noted that interoperability reforms can reduce friction only if health plans and providers adopt compatible systems and maintain accurate data exchange.

Which plans are affected?

The 2026 reporting and API requirements apply to:

Medicare Advantage plans.
State Medicaid and CHIP managed care plans.
Qualified Health Plans (QHPs) offered on the federally facilitated Marketplace.

Traditional Medicare (also called fee-for-service Medicare) is generally not subject to the same prior authorization structures as Medicare Advantage, though some services have separate review processes.

How patients can use this information in 2026

If you are choosing a plan during open enrollment, consider:

Looking up the plan’s prior authorization approval and denial rates.
Checking average response times, especially if you have chronic conditions requiring ongoing approvals.
Asking your clinician’s office whether certain plans are easier or harder to work with for common services.

If you face a delay or denial:

Request a clear written explanation.
Ask about the plan’s appeal process and deadlines.
Keep copies of medical records and prior authorization reference numbers.
For Medicare Advantage, you can contact 1-800-MEDICARE for assistance.

For families managing complex needs—such as children requiring therapies or older adults with multiple chronic conditions—tracking these metrics may help anticipate administrative hurdles.

What remains uncertain

Several open questions remain:

Will plans present data in ways that are easy for consumers to interpret?
Will public reporting meaningfully reduce inappropriate denials?
How will CMS monitor accuracy and consistency of reported metrics?

Transparency is a starting point. MedPAC and other policy experts have noted that oversight, enforcement, and beneficiary education are also important to ensure prior authorization is used appropriately.

The bottom line

Starting in 2026, prior authorization will be less of a black box. Patients and clinicians will be able to see, in measurable terms, how often requests are approved, denied, or delayed.

That does not eliminate paperwork or guarantee faster care. But it does create new public data that patients, clinicians, regulators, and researchers can use to evaluate how health plans manage access to treatment.

For everyday readers, the key is this: when comparing plans or appealing a denial, you may soon have clearer numbers on your side.

Sources

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.